Aller au contenu principal
Profil bibliographique

Francinne T. Tostes

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
35Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentPancreatic and Hepatic Oncology ResearchColorectal Cancer Surgical Treatments

Les publications récentes

Accès ouvert 2026 article OpenAlex

Global consensus for the screening, diagnosis, staging, treatment, and surveillance of ovarian cancer in areas of significant resource limitations: report from the International Gynecological Cancer Society consensus meeting

Fernando Maluf, Henrique Alkalay Helber, Francinne T. Tostes, Ligia A. Maluf et autres

Introduction: The objective of this consensus report is to provide practical, resource-stratified recommendations for the management of ovarian cancer in countries with limited resources, where direct application of international guidelines is often difficult. To address these challenges, recommendations were developed from a …

br, mx, ca, gt, ar, om, pe, sg, co, cl, pl, il, lb (code pays fourni par la source)

0 citations Frontiers in Oncology
Accès ouvert 2022 article OpenAlex

Clinical Course, Genetic, and Immunohistochemical Characterization of Solid Pseudopapillary Tumor of the Pancreas (Frantz Tumors) in a Brazilian Cohort

Francinne T. Tostes, Parisina Fraga Dutra Cabral de Carvalho, Raphael L. C. Araújo, Rodrigo Chaves Ribeiro et autres

Frantz tumors or solid pseudopapillary pancreatic neoplasm (SPN) are rare exocrine neoplasms that carry a favorable prognosis; they represent up to 3% of all tumors located in the region of the pancreas and have specific age and gender predispositions. In recent years, …

br (code pays fourni par la source)

10 citations Genes
Accès ouvert 2022 article OpenAlex

Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma

Francinne T. Tostes, Miguel Zugman, Vítor Ribeiro Paes, Gustavo Schvartsman

Malignant pleural mesothelioma (MPM) is a poor prognosis disease, patients who are deemed eligible for resection usually are submitted to a multimodal therapy treatment that involves neoadjuvant chemotherapy followed by extrapleural pneumectomy/pleural decortication and radiotherapy with a median overall survival of 13 …

br (code pays fourni par la source)

4 citations Frontiers in Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.